A carregar...
Profile of infliximab in the treatment of pediatric Crohn’s disease
In recent years, a novel biologic therapy with monoclonal antibodies against tumor necrosis factor-alpha has revolutionized the treatment of Crohn’s disease. Infliximab, the first biologic agent, has been demonstrated to considerably improve both clinical and endoscopic outcomes. In view of the grow...
Na minha lista:
| Publicado no: | Pediatric Health Med Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5683274/ https://ncbi.nlm.nih.gov/pubmed/29388577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PHMT.S64943 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|